Toxicogenomics of nanoparticulate delivery of etoposide: potential impact on nanotechnology in retinoblastoma therapy
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1868-6966
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Toxicogenomics of nanoparticulate delivery of etoposide: potential impact on nanotechnology in retinoblastoma therapy ; volume:2 ; number:1-6 ; day:17 ; month:12 ; year:2010 ; pages:21-36 ; date:12.2011
Cancer nanotechnology ; 2, Heft 1-6 (17.12.2010), 21-36, 12.2011
- Urheber
-
Mitra, Moutushy
- Beteiligte Personen und Organisationen
-
Dilnawaz, Fahima
Misra, Ranjita
Harilal, Anju
Verma, Rama Shenkar
Sahoo, Sanjeeb K.
Krishnakumar, Subramanian
SpringerLink (Online service)
- DOI
-
10.1007/s12645-010-0010-4
- URN
-
urn:nbn:de:1111-201609059488
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:46 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Mitra, Moutushy
- Dilnawaz, Fahima
- Misra, Ranjita
- Harilal, Anju
- Verma, Rama Shenkar
- Sahoo, Sanjeeb K.
- Krishnakumar, Subramanian
- SpringerLink (Online service)
Ähnliche Objekte (12)
Erratum to: Toxicogenomics of nanoparticulate delivery of etoposide: potential impact on nanotechnology in retinoblastoma therapy
Expression changes and impact of the extracellular matrix on etoposide resistant human retinoblastoma cell lines
Nanotechnology-based drug delivery systems
Nanotechnology-based strategies overcoming the challenges of retinoblastoma: a comprehensive overview and future perspectives
Molecular mechanisms of etoposide
Stimuli‐Responsive Nanotechnology for RNA Delivery
Nanotechnology-based advances in the efficient delivery of melatonin
Protein profiling of WERI-RB1 and etoposide-resistant WERI-ETOR reveals new insights into topoisomerase inhibitor resistance in retinoblastoma
Effects of ascorbic acid on TRP channel-mediated Ca2+ homeostasis and cell viability in etoposide-resistant and -sensitive retinoblastoma cells
Different transcriptome profiles between human retinoblastoma Y79 cells and an etoposide-resistant subline reveal a chemoresistance mechanism
Nanotechnology-based drug delivery for the treatment of CNS disorders
Retrograde Approach for Intra-arterial Chemotherapy Delivery in Retinoblastoma
Erratum to: Toxicogenomics of nanoparticulate delivery of etoposide: potential impact on nanotechnology in retinoblastoma therapy
Expression changes and impact of the extracellular matrix on etoposide resistant human retinoblastoma cell lines
Nanotechnology-based drug delivery systems
Nanotechnology-based strategies overcoming the challenges of retinoblastoma: a comprehensive overview and future perspectives
Molecular mechanisms of etoposide
Stimuli‐Responsive Nanotechnology for RNA Delivery
Nanotechnology-based advances in the efficient delivery of melatonin
Protein profiling of WERI-RB1 and etoposide-resistant WERI-ETOR reveals new insights into topoisomerase inhibitor resistance in retinoblastoma
Effects of ascorbic acid on TRP channel-mediated Ca2+ homeostasis and cell viability in etoposide-resistant and -sensitive retinoblastoma cells
Different transcriptome profiles between human retinoblastoma Y79 cells and an etoposide-resistant subline reveal a chemoresistance mechanism
Nanotechnology-based drug delivery for the treatment of CNS disorders
Retrograde Approach for Intra-arterial Chemotherapy Delivery in Retinoblastoma
Erratum to: Toxicogenomics of nanoparticulate delivery of etoposide: potential impact on nanotechnology in retinoblastoma therapy
Expression changes and impact of the extracellular matrix on etoposide resistant human retinoblastoma cell lines
Nanotechnology-based drug delivery systems
Nanotechnology-based strategies overcoming the challenges of retinoblastoma: a comprehensive overview and future perspectives
Molecular mechanisms of etoposide
Stimuli‐Responsive Nanotechnology for RNA Delivery
Nanotechnology-based advances in the efficient delivery of melatonin
Protein profiling of WERI-RB1 and etoposide-resistant WERI-ETOR reveals new insights into topoisomerase inhibitor resistance in retinoblastoma
Effects of ascorbic acid on TRP channel-mediated Ca2+ homeostasis and cell viability in etoposide-resistant and -sensitive retinoblastoma cells
Different transcriptome profiles between human retinoblastoma Y79 cells and an etoposide-resistant subline reveal a chemoresistance mechanism
Nanotechnology-based drug delivery for the treatment of CNS disorders